AusCann Group Holdings (ASX:AC8) obtained a AU$1 million loan from Endpoints Capital as an advance tax refund for its research and development activities, according to a Friday filing with the Australian bourse.
The advance incurs an interest rate of 16% per annum, with a minimum period of 90 days. The loan is expected to be repaid once the tax refund is received or by Nov. 30, whichever is earlier.
The advance is part of the cannabis drug developer's expected research and development tax incentive of AU$1.965 million for financial year 2024.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。